RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $521

Benzinga · 1d ago
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $496 to $521.